Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • HIV Status Does Not Impact on...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era

HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era

Show other versions (1)
Bibliographic Details
Main Authors: Montoto, S, Shaw, K, Okosun, J, Gandhi, S, Fields, P, Wilson, A, Shanyinde, M, Cwynarski, K, Marcus, R, de Vos, J, Young, A, Tenant-Flowers, M, Orkin, C, Johnson, M, Chilton, D, Gribben, J, Bower, M
Format: Conference item
Published: 2011
  • Holdings
  • Description
  • Other Versions (1)
  • Similar Items
  • Staff View

Similar Items

  • HIV Status does not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era
    by: Orkin, C, et al.
    Published: (2012)
  • HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.
    by: Montoto, S, et al.
    Published: (2012)
  • Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma
    by: Bhanu Vakkalanka, et al.
    Published: (2011-01-01)
  • The Use of Filgrastim in Patients with Hodgkin Lymphoma Receiving ABVD
    by: Adam F. Binder, et al.
    Published: (2017-10-01)
  • Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD
    by: Diego Villa, et al.
    Published: (2018-12-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs